Prosecution Insights
Last updated: August 17, 2026

Examiner: RAO, SAVITHA M

Tech Center 1600 • Art Units: 1600 1614 1621 1629 1691

This examiner grants 61% of resolved cases

Performance Statistics

60.6%
Allow Rate
+0.6% vs TC avg
1,208
Total Applications
+30.0%
Interview Lift
980
Avg Prosecution Days
Based on 1181 resolved cases, 2023–2026

Rejection Statute Breakdown

2.5%
§101 Eligibility
17.7%
§102 Novelty
40.0%
§103 Obviousness
23.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18281674 METHODS AND MATERIALS FOR TREATING CANCER Non-Final OA Mayo Foundation for Medical Education and Research
18292329 SLC26A3 INHIBITORS AND USE THEREOF Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
18769264 BENZOQUINOLONE INHIBITORS OF VMAT2 Non-Final OA Auspex Pharmaceuticals, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month